FDAnews Drug Daily Bulletin

BioSyent Pharma Signs Exclusive Licensing and Distribution Agreement for Two New Drug Products

Aug. 20, 2012
A A
BioSyent announced that its subsidiary BioSyent Pharma has signed an exclusive licensing and distribution agreement with a European partner for two new products that will be marketed by its hospital products division. The products will be launched after Health Canada approval.
Equities